Survival and RFS
Ten patients died and all died of relapse (Table OS of all participants. In 9 patients who achieved CR after CCAG plus DLI regimen, 3 ultimately experienced a second relapse after allo-HSCT. One of them had extramedullary relapse before she had bone marrow relapse. Two of them had bone marrow relapse and died of the second relapse (Table RFS of 9 patients who achieved CR with CCAG plus DLI regimen. One-year RFS: 83.3% (95% CI, 27.3–97.5%). 